Association between percent decline in serum total homocysteine and risk of first stroke

Xiao Huang1, Youbao Li1, Ping Li1

  • 1From the Department of Cardiology (X.H., P.L., H.B., X.C.), Second Affiliated Hospital, Nanchang University; Division of Nephrology (Y.L., B.W., F.F.H., X.Q.), Nanfang Hospital, Southern Medical University; National Clinical Research Center for Kidney Disease (Y.L., B.W., F.F.H., X.Q.); State Key Laboratory of Organ Failure Research (Y.L., B.W., F.F.H., X.Q.); Guangdong Provincial Institute of Nephrology (Y.L., B.W., F.F.H., X.Q.); Departments of Cardiology (J.L., Y.Z., Y. Huo), Pharmacy (Y. Cui), and Neurology (Y. Huang), Peking University First Hospital; Department of Cardiology (N.S.), Peking University People's Hospital, Beijing; Department of Hypertension (J.W.), The Shanghai Institute of Hypertension, Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai; Departments of Neurology (M.H.) and Cardiology (D.Y.), First People's Hospital, Lianyungang; Institute for Biomedicine and School of Health Administration (G.T.), Anhui Medical University, Hefei; and Department of Cardiology (Y. Chen), Chinese PLA General Hospital, Beijing, China.

Neurology
|October 15, 2017
PubMed

Insights

Reducing serum total homocysteine (tHcy) levels is linked to a lower risk of first stroke in Chinese adults. This finding suggests that tHcy reduction may indicate the effectiveness of folic acid in stroke prevention.

Area of Science:

  • Cardiovascular Research
  • Neurology
  • Clinical Trials

Background:

  • The China Stroke Primary Prevention Trial (CSPPT) investigated stroke prevention strategies.
  • Serum total homocysteine (tHcy) is a potential risk factor for cardiovascular events.
  • Understanding the impact of tHcy reduction on stroke risk is crucial for public health.

Purpose of the Study:

  • To determine if changes in serum total homocysteine (tHcy) levels correlate with the risk of experiencing a first stroke.
  • To analyze the association between the percentage decline in tHcy and stroke incidence within the CSPPT cohort.

Main Methods:

  • Analysis of 16,867 participants from the CSPPT with baseline and exit tHcy measurements.
  • Primary outcome: first-ever stroke. Secondary outcome: composite of cardiovascular events.
  • Calculation of percent tHcy decline: [(baseline tHcy - exit tHcy)/baseline tHcy × 100].

Main Results:

  • Participants with a first stroke showed a significantly lower percent decline in tHcy compared to those without stroke.
  • A 20% reduction in tHcy was associated with a 7% decrease in stroke risk (HR 0.93).
  • Greater tHcy reduction (tertiles 2-3) significantly lowered stroke risk, with benefits observed across various demographic and clinical subgroups.

Conclusions:

  • A significant association exists between percent lowering of serum tHcy and reduced first stroke risk in Chinese adults with hypertension.
  • Further confirmation may establish tHcy reduction as a valuable marker for folic acid treatment efficacy in stroke prevention.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...